Axsome Therapeutics Revenue and Competitors

Location

$207M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Axsome Therapeutics's estimated annual revenue is currently $4.8M per year.(i)
  • Axsome Therapeutics received $24.0M in venture funding in March 2019.
  • Axsome Therapeutics's estimated revenue per employee is $7,543
  • Axsome Therapeutics's total funding is $207M.

Employee Data

  • Axsome Therapeutics has 637 Employees.(i)
  • Axsome Therapeutics grew their employee count by 41% last year.

Axsome Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Clinical OperationsReveal Email/Phone
3
VP Program ManagementReveal Email/Phone
4
VP Clinical & RegulatoryReveal Email/Phone
5
General CounselReveal Email/Phone
6
Associate VP, Head Field MedicalReveal Email/Phone
7
SVP, Clinical Development & Medical Affairs sReveal Email/Phone
8
EVP, Head CommercialReveal Email/Phone
9
VP, Head Medical AffairsReveal Email/Phone
10
SVP , Commercial OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is Axsome Therapeutics?

Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of CNS disorders. Axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. The company is based in New York City.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$207M

Total Funding

637

Number of Employees

$4.8M

Revenue (est)

41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Axsome Therapeutics News

2022-04-17 - Axsome Therapeutics Shares Rally After Positive AXS-05 Update AXSM

Shares of Axsome Therapeutics Inc. rose more than 20% on Tuesday after the biopharmaceutical company reported positive developments in its...

2022-04-17 - Axsome Therapeutics (AXSM) Stock: Why The Price Surged Over 25% Today

The stock price of Axsome Therapeutics Inc (NASDAQ: AXSM) increased by over 25% pre-market today. Investors are responding positively to...

2022-04-17 - Why Axsome Therapeutics Is Jumping Higher on Tuesday

AXS-05 could be the first drug developed by Axsome Therapeutics to reach commercialization, but it probably won't become the company's first...

2019-09-08 - The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$105.3M638-1%$525M
#2
$35M640N/AN/A
#3
$35M6403%N/A
#4
$105.8M6410%$435M
#5
$181.9M641-13%N/A

Axsome Therapeutics Funding

DateAmountRoundLead InvestorsReference
2016-11-11$20.0MUndisclosedSilicon Valley BankArticle
2017-12-04$9.5MUndisclosedH.C. Wainwright & CoArticle
2019-03-07$24.0MUndisclosedSilicon Valley BankArticle